These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2343243)

  • 1. [The 1989 Bichat Conference. A new therapeutic orientation in arterial hypertension: the action of rilmenidine (Hyperium 1 mg) on the so-called imidazoline receptors].
    Fillastre JP; Dhib M
    Rev Prat; 1990 Apr; 40(11):1032-3. PubMed ID: 2343243
    [No Abstract]   [Full Text] [Related]  

  • 2. [New discoveries in the regulation of arterial pressure: endazoline, rilmenidine and imidazoline receptors].
    Safar ME
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():9-10. PubMed ID: 2517010
    [No Abstract]   [Full Text] [Related]  

  • 3. Imidazoline receptor agonist drugs: a new approach to the treatment of systemic hypertension.
    Yu A; Frishman WH
    J Clin Pharmacol; 1996 Feb; 36(2):98-111. PubMed ID: 8852385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical pharmacology of hypotensive drugs acting on central imidazoline receptors].
    Drzewoski J; Wiśniewska-Jarosińska M
    Pol Arch Med Wewn; 1998 Dec; 100(6):561-9. PubMed ID: 10405570
    [No Abstract]   [Full Text] [Related]  

  • 5. Imidazoline Receptors: A Novel Approach to Hypertension--the Contribution of Rilmenidine. Symposium proceedings. Milan, Italy, June 8, 1993.
    Am J Cardiol; 1994 Dec; 74(13):1A-65A. PubMed ID: 7998579
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs acting on imidazoline receptors: a review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection.
    Bousquet P; Feldman J
    Drugs; 1999 Nov; 58(5):799-812. PubMed ID: 10595861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Imidazol receptor agonists--new possibilities for treating hypertension].
    Nowicki M; Wiecek A; Chudek J
    Postepy Hig Med Dosw; 1995; 49(5):631-43. PubMed ID: 8677226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of rilmenidine, a selective I1 imidazoline receptor binding agent in diabetic hypertensive patients.
    Dupuy O; Bauduceau B; Mayaudon H
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):123S-126S. PubMed ID: 10921531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazoline receptors. A new concept in central regulation of the arterial blood pressure.
    Bousquet P; Feldman J; Tibirica E; Bricca G; Greney H; Dontenwill M; Stutzmann J; Belcourt A
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):47S-50S. PubMed ID: 1350728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unexpected central hypertensive effect of the new imidazoline compound benazoline.
    Bruban V; Feldman J; Dontenwill M; Greney H; Brasili L; Giannella M; Pigini M; Bousquet P
    Ann N Y Acad Sci; 1999 Jun; 881():102-5. PubMed ID: 10415903
    [No Abstract]   [Full Text] [Related]  

  • 11. Rilmenidine: a novel antihypertensive agent.
    Safar ME
    Am J Med; 1989 Sep; 87(3C):24S-29S. PubMed ID: 2571292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Central nervous system as a target for the new antihypertensive agents].
    Nurminen ML
    Duodecim; 1999; 115(20):2267-73. PubMed ID: 11973931
    [No Abstract]   [Full Text] [Related]  

  • 13. Implications of imidazolines and imidazoline receptors role at the vascular level.
    Serban DN; Nechifor M; Slătineanu SM
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):37-44. PubMed ID: 12089957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selectivity of a new antihypertensive agent, rilmenidine, for imidazoline receptors in the human brain].
    Bricca G; Dontenwill M; Feldman J; Belcourt A; Bousquet P
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1325-8. PubMed ID: 1979731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The imidazoline receptor and the central regulation of arterial pressure].
    Dontenwill M; Tibiriça E; Bricca G; Bousquet P
    Pathol Biol (Paris); 1993 Sep; 41(7):575-7. PubMed ID: 8255607
    [No Abstract]   [Full Text] [Related]  

  • 16. The high-risk hypertensive patient and the potential for brain imidazoline receptor binding by rilmenidine.
    Laragh JH
    Am J Cardiol; 1994 Dec; 74(13):31A-35A. PubMed ID: 7998583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rilmenidine on signal transduction mechanisms associated with alpha 2-adrenergic and imidazoline receptors in brain.
    Regunathan S; Bramwell S; Reis DJ
    Ann N Y Acad Sci; 1995 Jul; 763():290-4. PubMed ID: 7677339
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the sympathoinhibitory effect of rilmenidine mediated by alpha-2 adrenoceptors or imidazoline receptors?
    Urban R; Szabo B; Starke K
    J Pharmacol Exp Ther; 1994 Aug; 270(2):572-8. PubMed ID: 7915315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New trends in the treatment of arterial hypertension: identification of the I1 receptor and the pharmacology of imidazoline].
    Pavlović P
    Vojnosanit Pregl; 1998; 55(3):305-10. PubMed ID: 9720446
    [No Abstract]   [Full Text] [Related]  

  • 20. [From alpha 2-adrenergic to endazoline receptors].
    Bousquet P; Feldman J; Tibirica E; Bricca G; Molines A; Dontenwill M; Belcourt A
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():11-4. PubMed ID: 2560909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.